MYCHOICE Trademark Registration for Medical Test Kits
Summary
The USPTO has registered the trademark 'MYCHOICE' for medical test kits and related diagnostic services. The registration covers products and services for detecting gene mutations and other molecular indicators for therapy selection.
What changed
The United States Patent and Trademark Office (USPTO) has officially registered the trademark 'MYCHOICE' (TM85924750) for a range of medical products and services. This registration specifically covers medical test kits, including components for specimen collection and analysis, designed for the detection of gene mutations, gene expression profiles, and other molecular indicators. It also encompasses medical testing services for evaluating and selecting therapy or treatment regimens, identifying molecular profiles associated with successful therapies, and assessing treatment efficacy or toxicity.
This trademark registration signifies that the MYCHOICE brand is now officially protected for these specific goods and services within the United States. While this is a routine registration process and does not impose new regulatory obligations on other entities, companies operating in the medical testing and diagnostics space should be aware of this registered trademark. It may impact branding and product naming strategies for similar offerings, particularly concerning gene detection and therapy selection services.
Archived snapshot
Mar 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
MYCHOICE
Registered TM85924750 Kind: registered Mar 20, 2026
Abstract
Medical test kits consisting of test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens for the detection of gene mutations, gene expression profiles or other molecular indicators or markers for use in evaluating and selecting therapy or treatment regimens; Testing for medical purposes, namely, providing reference and clinical laboratory tests which detect gene mutations, gene expression profiles or other molecular indicators or markers to evaluate and select therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens and identifying molecular profiles associated with successful therapies or treatment regimens; medical testing services for evaluating the efficacy or toxicity of medical treatments
Filing Date
2013-05-06
Related changes
Get daily alerts for USPTO Trademarks - Medical Devices (Class 010)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Medical Devices (Class 010) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.